Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
33%
Ph phase_2
4
44%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 4Post-market surveillance
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(1)
Other(6)

Detailed Status

unknown6
Not yet recruiting1
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (57.1%)
Phase 43 (42.9%)

Trials by Status

not_yet_recruiting111%
recruiting111%
unknown667%
completed111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_4

Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study

NCT07454473
not_yet_recruitingphase_4

Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke

NCT06645522
unknownphase_4

Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol

NCT06248242
unknown

Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke

NCT05644223
unknown

Edaravone Dexborneol Combining With Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke

NCT05121883
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07454473Phase 4

Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study

Recruiting
NCT06645522Phase 4

Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke

Not Yet Recruiting
NCT06248242Phase 4

Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol

Unknown
NCT05644223

Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke

Unknown
NCT05121883

Edaravone Dexborneol Combining With Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke

Unknown
NCT04667637Phase 2

Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol

Completed
NCT04817527Phase 2

Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows

Unknown
NCT05035953Phase 2

Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke

Unknown
NCT04714177Phase 2

Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9